These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Amino acids of the human alpha1d-adrenergic receptor involved in antagonist binding. Nagaoka Y; Ahmed M; Hossain M; Bhuiyan MA; Ishiguro M; Nakamura T; Watanabe M; Nagatomo T J Pharmacol Sci; 2008 Jan; 106(1):114-20. PubMed ID: 18187928 [TBL] [Abstract][Full Text] [Related]
7. Phe310 in transmembrane VI of the alpha1B-adrenergic receptor is a key switch residue involved in activation and catecholamine ring aromatic bonding. Chen S; Xu M; Lin F; Lee D; Riek P; Graham RM J Biol Chem; 1999 Jun; 274(23):16320-30. PubMed ID: 10347189 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the alpha 1a-adrenergic receptor binding pocket of antagonists by radioligand binding assay. Ahmed M; Hossain M; Bhuiyan MA; Ishiguro M; Tanaka T; Muramatsu I; Nagatomo T Biol Pharm Bull; 2008 Apr; 31(4):598-601. PubMed ID: 18379048 [TBL] [Abstract][Full Text] [Related]
9. Dominant-negative activity of an alpha(1B)-adrenergic receptor signal-inactivating point mutation. Chen S; Lin F; Xu M; Hwa J; Graham RM EMBO J; 2000 Aug; 19(16):4265-71. PubMed ID: 10944109 [TBL] [Abstract][Full Text] [Related]
10. Activation of the alpha1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. Porter JE; Hwa J; Perez DM J Biol Chem; 1996 Nov; 271(45):28318-23. PubMed ID: 8910453 [TBL] [Abstract][Full Text] [Related]
11. Characteristics for a salt-bridge switch mutation of the alpha(1b) adrenergic receptor. Altered pharmacology and rescue of constitutive activity. Porter JE; Perez DM J Biol Chem; 1999 Dec; 274(49):34535-8. PubMed ID: 10574914 [TBL] [Abstract][Full Text] [Related]
12. The agonism and synergistic potentiation of weak partial agonists by triethylamine in alpha 1-adrenergic receptor activation: evidence for a salt bridge as the initiating process. Porter JE; Edelmann SE; Waugh DJ; Piascik MT; Perez DM Mol Pharmacol; 1998 Apr; 53(4):766-71. PubMed ID: 9547369 [TBL] [Abstract][Full Text] [Related]
14. Influence of a lysine 331 counterion on the pK(a) of aspartic acid 125: evidence for a salt-bridge interaction and role in alpha(1b)-adrenergic receptor activation. Porter JE; Perez DM J Pharmacol Exp Ther; 2000 Jan; 292(1):440-8. PubMed ID: 10604981 [TBL] [Abstract][Full Text] [Related]
16. Novel human alpha1a-adrenoceptor single nucleotide polymorphisms alter receptor pharmacology and biological function. Lei B; Morris DP; Smith MP; Svetkey LP; Newman MF; Rotter JI; Buchanan TA; Beckstrom-Sternberg SM; Green ED; Schwinn DA Naunyn Schmiedebergs Arch Pharmacol; 2005 Mar; 371(3):229-39. PubMed ID: 15900517 [TBL] [Abstract][Full Text] [Related]
17. Phe(303) in TMVI of the alpha(1B)-adrenergic receptor is a key residue coupling TM helical movements to G-protein activation. Chen S; Lin F; Xu M; Graham RM Biochemistry; 2002 Jan; 41(2):588-96. PubMed ID: 11781098 [TBL] [Abstract][Full Text] [Related]
18. Bulk is a determinant of oxymetazoline affinity for the alpha1A-adrenergic receptor. McCune D; Gaivin R; Rorabaugh B; Perez D Recept Channels; 2004; 10(3-4):109-16. PubMed ID: 15512845 [TBL] [Abstract][Full Text] [Related]
19. Site-directed mutagenesis of alpha 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Wang CD; Buck MA; Fraser CM Mol Pharmacol; 1991 Aug; 40(2):168-79. PubMed ID: 1678850 [TBL] [Abstract][Full Text] [Related]
20. Amino acids of the alpha1B-adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypes. Cavalli A; Fanelli F; Taddei C; De Benedetti PG; Cotecchia S FEBS Lett; 1996 Dec; 399(1-2):9-13. PubMed ID: 8980109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]